A Prognostic Signature for Colon Adenocarcinoma Patients Based on m6A-Related lncRNAs

Figure 6

The correlation of risk score and clinical characteristics. (a) Heatmap of m6A-lncRNAs expression, immune score, and clinical features in low- and high-risk score subgroup. (b) Distribution of PD-L1 expression stratified by risk scores. (c, d) Distribution of risk scores stratified by clusters and immune score.

(a)

(b)

(c)

(d)